.25 mg semaglutide in syringe 25 Why do you need to use an insulin syringe to administer Semaglutide Pre-Filled Injection 0.25mg |

As the use of GLP-1 receptor agonists continues to expand for the treatment of type 2 diabetes and obesity, questions have emerged about their potential gastrointestinal side effectsparticularly gastroesophageal reflux disease (GERD)

Taking a GLP-1 and hitting a weight plateau

See real tirzepatide before and after weight loss timelines from a bariatric specialist

It mimics the action of the natural hormone GLP-1 which is released from the small intestine.1 GLP-1 mainly acts in three ways on glucose and these actions are mediated by the GLP-1 receptors.1 []

Strategies to ensure GLP1 access equity in diabetes and obesity care, prioritizing highrisk patients and promoting fair, datadriven treatment access.